Johnson & Johnson - Sep 30, 2025 SCHEDULE 13G/A Report for Rapport Therapeutics, Inc. Common Stock, $0.001 par value (RAPP)

Filing Manager
JOHNSON & JOHNSON
Reporting Manager
JOHNSON & JOHNSON
Security
Rapport Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RAPP
Shares outstanding
36.4M shares
Disclosed Ownership
1.78M shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Date filed
10/22/2025, 05:09 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JOHNSON & JOHNSON 4.9% 1.78M 0 1.78M /s/ Marc Larkins Mark Larkins/Secretary
Johnson & Johnson Innovation - JJDC, Inc. 4.9% 1.78M 0 1.78M /s/ Jill McManus Jill McManus/Assistant Treasurer